Suppr超能文献

用针对白细胞介素2受体的单克隆抗体治疗抑制大鼠局部移植物抗宿主反应。

Suppression of the local graft-vs.-host reaction in rats by treatment with a monoclonal antibody specific for the interleukin 2 receptor.

作者信息

Volk H D, Brocke S, Osawa H, Diamantstein T

出版信息

Eur J Immunol. 1986 Oct;16(10):1309-12. doi: 10.1002/eji.1830161020.

Abstract

Local graft-vs.-host reaction (GVHR) was induced in rats by injecting parental cells into young F1 recipients. As a consequence of antigenic stimulation in the course of developing GVHR in the responding lymph nodes, the number of interleukin 2-receptor (IL 2R)-bearing T cells increased from less than 1% up to 10% of the total population. The IL 2R-bearing cells were located mainly in the T cell areas of the reactive lymph nodes. As assessed by the determination of the GVHR indices, treatment of the recipients with anti-T-helper subset-specific mAb (W3/25) or with anti-IL 2R mAb (ART-18) inhibited the GVHR. In parallel, the number of IL 2R-bearing cells was reduced to the normal levels. W3/25 mAb treatment changed the helper/suppressor subset ratio and reduced the number of circulating lymphocytes in the peripheral blood. In contrast, ART-18 mAb treatment did not induce any detectable changes in the subset distribution and it did not affect the number of circulating lymphocytes. The results demonstrate the key role that the IL 2R-positive cells play in the proliferative phase of acute GVHR, and favor the use of anti-IL 2R mAb as selective immunosuppressive agents.

摘要

通过将亲代细胞注射到年轻的F1受体大鼠体内,诱导其发生局部移植物抗宿主反应(GVHR)。在反应性淋巴结中发生GVHR的过程中,由于抗原刺激,携带白细胞介素2受体(IL-2R)的T细胞数量从占总细胞数的不到1%增加到10%。携带IL-2R的细胞主要位于反应性淋巴结的T细胞区域。通过测定GVHR指数评估,用抗T辅助亚群特异性单克隆抗体(W3/25)或抗IL-2R单克隆抗体(ART-18)治疗受体可抑制GVHR。同时,携带IL-2R的细胞数量减少至正常水平。W3/25单克隆抗体治疗改变了辅助/抑制亚群比例,并减少了外周血中循环淋巴细胞的数量。相比之下,ART-18单克隆抗体治疗未引起亚群分布的任何可检测变化,也未影响循环淋巴细胞的数量。结果表明,IL-2R阳性细胞在急性GVHR增殖期发挥关键作用,并支持将抗IL-2R单克隆抗体用作选择性免疫抑制剂。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验